For the first quarter Humana reported earnings of $2.35 a share, beating the Capital IQ Consensus Estimate of $1.94 a share by 41 cents. Revenue grew 11.7% year-over year to $11.7 billion for the quarter. Analysts expected revenue of $11.5 billion for the quarter.
Looking forward to full-year 2014 Humana expect EPS of $7.25 to $7.75 a share. The company expects Medicare Advantage membership to grow by 395,000 to 435,000 for the year.
Must read: Warren Buffett's 10 Favorite Growth Stocks
TheStreet Ratings team rates HUMANA INC as a Buy with a ratings score of B. TheStreet Ratings Team has this to say about their recommendation:
"We rate HUMANA INC (HUM) a BUY. This is driven by several positive factors, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, largely solid financial position with reasonable debt levels by most measures and reasonable valuation levels. We feel these strengths outweigh the fact that the company has had sub par growth in net income."